FGF21 and obesity disorder: Paradoxically, FGF21 levels are elevated in obesity [15] and obese mice treated with recombinant FGF21 have a blunted metabolic response to FGF21, which suggests that resistance to the actions of FGF21 may develop in obesity [16].